| Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ... European urology 74 (4), 455-462, 2018 | 299 | 2018 |
| Urethral stricture following high dose rate brachytherapy for prostate cancer L Sullivan, SG Williams, KH Tai, F Foroudi, L Cleeve, GM Duchesne Radiotherapy and Oncology 91 (2), 232-236, 2009 | 171 | 2009 |
| Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study F Foroudi, J Wong, T Kron, A Rolfo, A Haworth, P Roxby, J Thomas, ... International Journal of Radiation Oncology* Biology* Physics 81 (3), 765-771, 2011 | 156 | 2011 |
| High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial M Barkati, SG Williams, F Foroudi, KH Tai, S Chander, S van Dyk, A See, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 1889-1896, 2012 | 147 | 2012 |
| A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. S Siva, D Pham, S Gill, NM Corcoran, F Foroudi BJU international 110, 2012 | 145 | 2012 |
| Occult breast carcinoma presenting as axillary metastases F Foroudi, KW Tiver International Journal of Radiation Oncology* Biology* Physics 47 (1), 143-147, 2000 | 127 | 2000 |
| Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy S Gill, J Thomas, C Fox, T Kron, A Rolfo, M Leahy, S Chander, S Williams, ... Radiation oncology 6, 1-7, 2011 | 122 | 2011 |
| Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial S Siva, D Pham, T Kron, M Bressel, J Lam, TH Tan, B Chesson, M Shaw, ... BJU international 120 (5), 623-630, 2017 | 110 | 2017 |
| Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review G Kothari, F Foroudi, S Gill, NM Corcoran, S Siva Acta oncologica 54 (2), 148-157, 2015 | 109 | 2015 |
| Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from … S Tyldesley, G Delaney, F Foroudi, L Barbera, M Kerba, W Mackillop International Journal of Radiation Oncology* Biology* Physics 79 (5), 1507-1515, 2011 | 109 | 2011 |
| Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer R Khor, G Duchesne, KH Tai, F Foroudi, S Chander, S Van Dyk, M Garth, ... International Journal of Radiation Oncology* Biology* Physics 85 (3), 679-685, 2013 | 103 | 2013 |
| Psychological adjustment of survivors of localised prostate cancer: investigating the role of dyadic adjustment, cognitive appraisal and coping style AC Wootten, S Burney, F Foroudi, M Frydenberg, G Coleman, KT Ng Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2007 | 95 | 2007 |
| Intra-fraction prostate displacement in radiotherapy estimated from pre-and post-treatment imaging of patients with implanted fiducial markers T Kron, J Thomas, C Fox, A Thompson, R Owen, A Herschtal, A Haworth, ... Radiotherapy and Oncology 95 (2), 191-197, 2010 | 88 | 2010 |
| An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer F Foroudi, S Tyldesley, H Walker, WJ Mackillop International Journal of Radiation Oncology* Biology* Physics 53 (5), 1240-1253, 2002 | 79 | 2002 |
| Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity D Pham, A Thompson, T Kron, F Foroudi, MS Kolsky, T Devereux, A Lim, ... International Journal of Radiation Oncology* Biology* Physics 90 (5), 1061-1068, 2014 | 77 | 2014 |
| Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship S Siva, P Jackson, T Kron, M Bressel, E Lau, M Hofman, M Shaw, ... Radiotherapy and Oncology 118 (3), 540-546, 2016 | 75 | 2016 |
| TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney-FASTRACK II S Siva, B Chesson, M Bressel, D Pryor, B Higgs, HM Reynolds, ... BMC cancer 18, 1-10, 2018 | 71 | 2018 |
| Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy D Kok, S Gill, M Bressel, K Byrne, T Kron, C Fox, G Duchesne, KH Tai, ... Radiotherapy and Oncology 107 (2), 140-146, 2013 | 70 | 2013 |
| Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: a prospective clinical trial S David, J Tan, P Savas, M Bressel, D Kelly, F Foroudi, S Loi, S Siva The Breast 49, 55-62, 2020 | 67 | 2020 |
| Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer F Foroudi, S Tyldesley, L Barbera, J Huang, WJ Mackillop International Journal of Radiation Oncology* Biology* Physics 55 (1), 51-63, 2003 | 67 | 2003 |
